TIP: Tinengotinib In Prostate Cancer - Clinical Trial
Who Can Participate in the Study?
Grupo etario
Adultos
Study Details
Full Title
A Phase 1b/2 Study Evaluating the Activity of Tinengotinib (TT-00420) in Combination with Androgen Receptor Signaling Inhibitors (ARSIs) in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC)
Principal Investigator
Especialista en oncología médica
Protocol Number
IRB:
PRO00116180
NCT:
NCT06457919
Phase
Phase
I/II
ClinicalTrials.gov
View on ClinicalTrials.gov
Estado de inscripción
Abierto para inscripción